LifeMD, Inc.
LFMD
$4.28
-$0.11-2.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 218.31M | 219.03M | 177.65M | 170.75M | 161.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 218.31M | 219.03M | 177.65M | 170.75M | 161.57M |
| Cost of Revenue | 26.79M | 29.00M | 29.78M | 27.38M | 24.98M |
| Gross Profit | 191.52M | 190.03M | 147.87M | 143.37M | 136.59M |
| SG&A Expenses | 185.24M | 176.75M | 142.54M | 141.09M | 137.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 11.09M | 10.29M | 9.27M | 8.47M | 7.49M |
| Total Operating Expenses | 232.32M | 225.30M | 188.79M | 183.92M | 176.98M |
| Operating Income | -14.02M | -6.27M | -11.14M | -13.17M | -15.41M |
| Income Before Tax | -16.02M | -8.79M | -14.29M | -15.46M | -17.57M |
| Income Tax Expenses | 183.00K | 183.00K | 534.60K | 598.00K | 598.00K |
| Earnings from Continuing Operations | -16.20 | -8.97 | -14.83 | -16.06 | -18.17 |
| Earnings from Discontinued Operations | 21.03M | 23.02M | 1.99M | 1.99M | 1.99M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -733.90K | -1.27M | -1.60M | -1.22M | -961.30K |
| Net Income | 4.10M | 12.79M | -12.12M | -12.97M | -14.82M |
| EBIT | -14.02M | -6.27M | -11.14M | -13.17M | -15.41M |
| EBITDA | -12.40M | -4.82M | -10.57M | -12.73M | -15.07M |
| EPS Basic | 0.02 | 0.20 | -0.35 | -0.38 | -0.43 |
| Normalized Basic EPS | -0.22 | -0.13 | -0.23 | -0.26 | -0.28 |
| EPS Diluted | 0.02 | 0.20 | -0.35 | -0.38 | -0.43 |
| Normalized Diluted EPS | -0.22 | -0.13 | -0.23 | -0.26 | -0.28 |
| Average Basic Shares Outstanding | 184.70M | 180.50M | 174.92M | 170.78M | 167.66M |
| Average Diluted Shares Outstanding | 184.70M | 180.50M | 174.92M | 170.78M | 167.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 75.83% | 24.30% | -25.64% | -23.95% | -20.95% |